Topic

Aetna (CVS Health)

A collection of 1351 issues

How to Get Vitrakvi (Larotrectinib) Covered by Aetna CVS Health in Illinois: PA Forms, Appeal Scripts & Timeline Guide

Quick Answer: Aetna CVS Health requires prior authorization for Vitrakvi (larotrectinib) with documented NTRK gene fusion testing and evidence of metastatic/unresectable disease. Submit PA via CVS Specialty at 1-888-267-3277 with molecular pathology report, oncologist notes, and prior therapy documentation. If denied, appeal within 180 days using medical necessity letter
5 min read

How to Get Helixate (Antihemophilic Factor, rFVIII) Covered by Aetna CVS Health in Michigan: Complete Coverage Guide with Appeals Process

Quick Answer: Getting Helixate Covered by Aetna CVS Health in Michigan Important Update: Helixate (antihemophilic factor, rFVIII) has been discontinued by the manufacturer. Aetna CVS Health now covers alternative factor VIII products like Kovaltry, Advate, and Jivi with prior authorization. First step: Contact your hematologist to select an alternative and
4 min read

How to Get Oxlumo (Lumasiran) Covered by Aetna (CVS Health) in Illinois: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Oxlumo Covered by Aetna (CVS Health) in Illinois Aetna (CVS Health) covers Oxlumo (lumasiran) for primary hyperoxaluria type 1 (PH1) with prior authorization. To get approval: (1) Your nephrologist or geneticist submits a precertification request with confirmed PH1 diagnosis (genetic testing showing AGXT mutation or enzyme analysis)
6 min read